Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Plasma cell 2Classical hematology 2Other hematologic neoplasm 1

Conditions

Thrombocytopenia 7Neoplasms 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Purpura, Thrombocytopenic, Idiopathic 1Purpura, Thrombocytopenic 1Lung Neoplasms 1Glioblastoma 1Chemotherapy-induced Thrombocytopenia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 34fludarabine phosphate 32Mycophenolic Acid 27Whole-Body Irradiation 21Peripheral Blood Stem Cell Transplantation 21Tacrolimus 19Melphalan 18Cyclosporine 17fludarabine 16Busulfan 16Antilymphocyte Serum 16Filgrastim 12Cord Blood Stem Cell Transplantation 9Methotrexate 8Radiotherapy 7Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Sirolimus 5Rituximab 5Epoetin Alfa 5Etoposide 4Cytarabine 4Alemtuzumab 4thymoglobulin 3Therapeutics 3Stem Cell Transplantation 3Darbepoetin alfa 3Clofarabine 3CT-P10 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hodgkin Disease × romiplostim × Classical hematology × Clear all
NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
62 enrolled 7 charts
Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT00283439 2011-06-20

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Amgen

Phase 1/2 Completed
39 enrolled 13 charts
Classical hematologyLymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡